Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,otherCashflowsFromFinancingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,priceHint,shortName,exchange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,exchangeDataDelayedBy,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,marketState,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,GPHG,15115508.0,37283200,,,5322457,341944,3735881,3471019,9571782,6100763,6100763,,-129740,,,,1589240,68999093,62898330,59427311,-778306,,3733217,3735881,33860597.0,55089340.0,84872616.0,76019956.0,2295065.0,161234516.0,37283.0,9137269.0,20755715.0,18982662.0,27043851.0,137618.0,18570246.0,59889963.0,137618.0,8505797.0,91824271.0,34069776.0,5999991.0,29852272.0,39900624.0,5287314.0,-76237.0,8736956.0,8736956.0,-1488951.0,9425412.0,-9484.0,774177.0,616711.0,-5839922.0,-2022146.0,663070.0,-129929.0,,31934308.0,en-US,US,EQUITY,False,Delayed Quote,0.0016,1629817057,0.0,0.0016,0.0016,0.0016,3557,-0.37030986,-0.9956979,67109,0.00078469835,15,America/New_York,EDT,-14400000,False,False,USD,4,GLOBAL PHARM HLDGS GROUP INC,PNK,2.039,0.38642222,-0.38482222,-0.99585944,0.37190986,0,finmb_111807875,Other OTC,"Global Pharm Holdings Group, Inc.",USD,200,444,0.0,0.0,0.0016 - 1.0101,-1.0085,-0.99841595,0.0016,1.0101,1561042740,1561042740,1561042740,0.001997503,0.801,PREPRE,0.0,0.0016 - 0.0016,0.0016,us_market,102.91,,,1.0101,0.0016,0.3864,0.3719,200,444,37.28M,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2010","Sep 29, 2011",8.89%,10.20%,12.52%,42.35%,206.33M,9.19,125.40%,26.41M,21.74M,18.34M,0.8010,,18.57M,0.5,16.39M,21.47,1.53,2.04,11.74M,-5.45M,Value,518026,Healthcare,500,"Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. It distributes prescription and non-prescription drugs in the form of injections, tablets, pastes, granules, and capsules for various diseases. The company is also involved in the cultivation, processing, and sale of Chinese herbs, such as wild ginseng, chrysanthemum, salvia, angelica, wind, schisandra, rana, etc. In addition, it sells biochemical drugs, cosmetics, pre-packaged food, and medical devices. The company markets its products directly to hospitals, clinics, pharmacies and drugstores, and other healthcare institutions. Global Pharm Holdings Group, Inc. is based in Shenzhen, China. As of December 31, 2018, Global Pharm Holdings Group, Inc. operates as a subsidiary of Fortune Insight Limited.",Shenzhen,86 755 8352 1616,1293753600,China,http://www.globalpharmholdings.com,86400,Rongchao Tower,86 755 8303 9671,Drug Manufacturers—Specialty & Generic,"29th Floor, Tower B No. 6003 Yitian Road Futian District"
t-1,GPHG,26662384.0,37283200,,,5431251,344582,3919607,1924123,7382949,5458826,5458826,,-10798,,,,1513005,45386335,39927509,38003386,-27575,,3918246,3919607,297874.0,9200623.0,29905508.0,27334401.0,3582830.0,57584491.0,26000.0,3192121.0,17075663.0,,374143.0,1032115.0,9144834.0,29905508.0,1032115.0,676529.0,56235945.0,24918594.0,,18980396.0,22023372.0,-3890513.0,-824549.0,1084936.0,1429771.0,99708.0,239066.0,137600.0,-503756.0,37124.0,18151.0,-999101.0,-1353.0,-257158.0,344835.0,26330437.0,en-US,US,EQUITY,False,Delayed Quote,0.0016,1629817057,0.0,0.0016,0.0016,0.0016,3557,-0.37030986,-0.9956979,67109,0.00078469835,15,America/New_York,EDT,-14400000,False,False,USD,4,GLOBAL PHARM HLDGS GROUP INC,PNK,2.039,0.38642222,-0.38482222,-0.99585944,0.37190986,0,finmb_111807875,Other OTC,"Global Pharm Holdings Group, Inc.",USD,200,444,0.0,0.0,0.0016 - 1.0101,-1.0085,-0.99841595,0.0016,1.0101,1561042740,1561042740,1561042740,0.001997503,0.801,PREPRE,0.0,0.0016 - 0.0016,0.0016,us_market,102.91,,,1.0101,0.0016,0.3864,0.3719,200,444,37.28M,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2010","Sep 29, 2011",8.89%,10.20%,12.52%,42.35%,206.33M,9.19,125.40%,26.41M,21.74M,18.34M,0.8010,,18.57M,0.5,16.39M,21.47,1.53,2.04,11.74M,-5.45M,Value,518026,Healthcare,500,"Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. It distributes prescription and non-prescription drugs in the form of injections, tablets, pastes, granules, and capsules for various diseases. The company is also involved in the cultivation, processing, and sale of Chinese herbs, such as wild ginseng, chrysanthemum, salvia, angelica, wind, schisandra, rana, etc. In addition, it sells biochemical drugs, cosmetics, pre-packaged food, and medical devices. The company markets its products directly to hospitals, clinics, pharmacies and drugstores, and other healthcare institutions. Global Pharm Holdings Group, Inc. is based in Shenzhen, China. As of December 31, 2018, Global Pharm Holdings Group, Inc. operates as a subsidiary of Fortune Insight Limited.",Shenzhen,86 755 8352 1616,1293753600,China,http://www.globalpharmholdings.com,86400,Rongchao Tower,86 755 8303 9671,Drug Manufacturers—Specialty & Generic,"29th Floor, Tower B No. 6003 Yitian Road Futian District"
t-2,GPHG,23068736.0,37283200,,,6666561,344582,5291514,1152069,7824651,6672582,6672582,,-10747,,,,1375047,42120757,35448175,34296106,-6021,,5291514,5291514,,9200623.0,28259969.0,23068736.0,1381627.0,51328705.0,26000.0,1319235.0,13148621.0,,,693492.0,8905768.0,28259969.0,693492.0,238795.0,51089910.0,23127696.0,,17737211.0,24752556.0,3657596.0,-45560.0,-1130041.0,-1130041.0,1578525.0,4634270.0,47769.0,5762102.0,18894.0,-1569016.0,-3215411.0,-1353.0,-45560.0,344835.0,22829941.0,en-US,US,EQUITY,False,Delayed Quote,0.0016,1629817057,0.0,0.0016,0.0016,0.0016,3557,-0.37030986,-0.9956979,67109,0.00078469835,15,America/New_York,EDT,-14400000,False,False,USD,4,GLOBAL PHARM HLDGS GROUP INC,PNK,2.039,0.38642222,-0.38482222,-0.99585944,0.37190986,0,finmb_111807875,Other OTC,"Global Pharm Holdings Group, Inc.",USD,200,444,0.0,0.0,0.0016 - 1.0101,-1.0085,-0.99841595,0.0016,1.0101,1561042740,1561042740,1561042740,0.001997503,0.801,PREPRE,0.0,0.0016 - 0.0016,0.0016,us_market,102.91,,,1.0101,0.0016,0.3864,0.3719,200,444,37.28M,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2010","Sep 29, 2011",8.89%,10.20%,12.52%,42.35%,206.33M,9.19,125.40%,26.41M,21.74M,18.34M,0.8010,,18.57M,0.5,16.39M,21.47,1.53,2.04,11.74M,-5.45M,Value,518026,Healthcare,500,"Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. It distributes prescription and non-prescription drugs in the form of injections, tablets, pastes, granules, and capsules for various diseases. The company is also involved in the cultivation, processing, and sale of Chinese herbs, such as wild ginseng, chrysanthemum, salvia, angelica, wind, schisandra, rana, etc. In addition, it sells biochemical drugs, cosmetics, pre-packaged food, and medical devices. The company markets its products directly to hospitals, clinics, pharmacies and drugstores, and other healthcare institutions. Global Pharm Holdings Group, Inc. is based in Shenzhen, China. As of December 31, 2018, Global Pharm Holdings Group, Inc. operates as a subsidiary of Fortune Insight Limited.",Shenzhen,86 755 8352 1616,1293753600,China,http://www.globalpharmholdings.com,86400,Rongchao Tower,86 755 8303 9671,Drug Manufacturers—Specialty & Generic,"29th Floor, Tower B No. 6003 Yitian Road Futian District"
t-3,GPHG,17628164.0,37283200,,,6615490,344582,5444050,3233854,9856084,6622230,6622230,,-10134,,,,1171440,50166273,43544043,40310189,-6740,,5444050,5444050,,9200623.0,25549289.0,17628164.0,1247239.0,43177453.0,26000.0,1538251.0,7857107.0,,,544434.0,4271498.0,25549289.0,544434.0,210665.0,42966788.0,19940870.0,,16058760.0,20013157.0,-5359556.0,-24472.0,161633.0,-9130679.0,-766097.0,-3558793.0,-106340.0,5702698.0,16175.0,8026581.0,-2763243.0,1496811.0,-85908.0,-9292312.0,17417499.0,en-US,US,EQUITY,False,Delayed Quote,0.0016,1629817057,0.0,0.0016,0.0016,0.0016,3557,-0.37030986,-0.9956979,67109,0.00078469835,15,America/New_York,EDT,-14400000,False,False,USD,4,GLOBAL PHARM HLDGS GROUP INC,PNK,2.039,0.38642222,-0.38482222,-0.99585944,0.37190986,0,finmb_111807875,Other OTC,"Global Pharm Holdings Group, Inc.",USD,200,444,0.0,0.0,0.0016 - 1.0101,-1.0085,-0.99841595,0.0016,1.0101,1561042740,1561042740,1561042740,0.001997503,0.801,PREPRE,0.0,0.0016 - 0.0016,0.0016,us_market,102.91,,,1.0101,0.0016,0.3864,0.3719,200,444,37.28M,,,,,,,,,,,,,,,0.00%,,,,,"Dec 30, 2010","Sep 29, 2011",8.89%,10.20%,12.52%,42.35%,206.33M,9.19,125.40%,26.41M,21.74M,18.34M,0.8010,,18.57M,0.5,16.39M,21.47,1.53,2.04,11.74M,-5.45M,Value,518026,Healthcare,500,"Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China. It distributes prescription and non-prescription drugs in the form of injections, tablets, pastes, granules, and capsules for various diseases. The company is also involved in the cultivation, processing, and sale of Chinese herbs, such as wild ginseng, chrysanthemum, salvia, angelica, wind, schisandra, rana, etc. In addition, it sells biochemical drugs, cosmetics, pre-packaged food, and medical devices. The company markets its products directly to hospitals, clinics, pharmacies and drugstores, and other healthcare institutions. Global Pharm Holdings Group, Inc. is based in Shenzhen, China. As of December 31, 2018, Global Pharm Holdings Group, Inc. operates as a subsidiary of Fortune Insight Limited.",Shenzhen,86 755 8352 1616,1293753600,China,http://www.globalpharmholdings.com,86400,Rongchao Tower,86 755 8303 9671,Drug Manufacturers—Specialty & Generic,"29th Floor, Tower B No. 6003 Yitian Road Futian District"
